TIL Instil Bio, Inc.

$7.53 -0.26%

Healthcare · Biological Products, (No Diagnostic Substances)

Instil Bio, Inc. (TIL) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $51 million. Shares last traded at $7.53, 77.6% below their 52-week high. Over the past year the stock is down 77.0%. Revenue declined 100.0% year over year.

Market Cap

$51M

Shares Out

6.8M

EPS (TTM)

$-22.02

P/E Ratio

—

P/S Ratio

—

P/B Ratio

0.46

Dividend / Share

—

Dividend Yield

—

52-Week High

$33.61

52-Week Low

$5.40

Volume

593

Avg Vol (3m)

854.905

Performance

-5.64%

-7.27%

-9.71%

-31.76%

YTD

-34.18%

-77.04%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

28.28

SMA (50)

$8.15

SMA (200)

$11.78

Price vs SMA50

-7.59%

Price vs SMA200

-36.08%

ATR (14)

$0.22

Financials

Revenue

$0M

Net Income

$-71M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

-64.5%

Return on Assets

-35.6%

Current Ratio

39.87

Debt / Equity

0.81

Revenue Growth (YoY)

-100.0%

Latest reported annual period ending 2021-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.62	2026-05-15
FY 2025	$-10.70	2026-03-27
Q3 2025	$-9.53	2025-11-13
Q2 2025	$-7.55	2025-08-13
Q1 2026	$-4.32	2026-05-15
FY 2025	$-11.39	2026-03-27

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

TIL vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap.

1–14 of 14


AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
RVMD	Revolution Medicines, Inc.	$34.6B	-30.62	—	—	+3.14%
BIIB	Biogen	$29.0B	22.44	2.93	13.1%	-1.15%
MRNA	Moderna	$25.4B	-8.99	—	—	+3.22%
NBIX	Neurocrine Biosciences Inc	$15.9B	33.24	5.56	16.7%	-0.48%
EXEL	Exelixis, Inc.	$13.1B	16.68	5.62	33.7%	-1.04%
KRYS	Krystal Biotech, Inc.	$10.2B	50.02	26.33	52.6%	+1.68%
TECH	Bio-Techne	$9.1B	123.61	7.44	6.0%	+5.36%
HALO	Halozyme Therapeutics, Inc.	$8.1B	25.67	5.82	22.7%	-0.03%
IBRX	Immunitybio, Inc.	$7.7B	-21.87	—	—	+5.01%
RGEN	Repligen Corp	$7.4B	152.27	10.08	6.6%	-1.20%
KYMR	Kymera Therapeutics, Inc.	$7.4B	23.88	—	—	+0.44%
PCVX	Vaxcyte, Inc.	$7.4B	-9688.00	—	—	+1.57%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.